Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody –Associated Vasculitis: A Randomized Controlled Study

ConclusionBelimumab plus azathioprine and glucocorticoids for the maintenance of remission in AAV did not reduce the risk of relapse.

Source: Arthritis and Rheumatology - April 15, 2019 Category: Rheumatology Authors: David Jayne, Daniel Blockmans, Raashid Luqmani, Sergey Moiseev, Beulah Ji, Yulia Green, Leanne Hall, David Roth, Robert B. Henderson, Peter A. Merkel, Jose Alfaro Lozano, Heidemarie Becker, Armando Calvo Quiroz, Simon Carette, Sandra Carrill Tags: Original Article Source Type: research